9th Circ. Keeps Investor Class Intact In Anemia Drug Fight
In seeking to overturn class certification, Amgen contended that the district judge should not have certified the class because the group of Connecticut pension funds filing suit had not proven Amgen's alleged misstatements were material.
However, the pension funds had only to plausibly allege — not prove...
To view the full article, register now.